Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Enrico Traverso

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Transactions of the American Ophthalmological Society|November 24, 2017
The Effects of Phacoemulsification and Intraocular Lens Implantation on Anatomical and Functional Parameters in Patients with Primary Angle Closure: A Prospective Study. (An American Ophthalmological Society Thesis)Carlo Enrico Traverso, Carlo Alberto Cutolo
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 13, 2019
Comparison of the Efficacy of Topical Chloramphenicol 0.5%-Betamethasone 0.2% (CB) and CB Associated with Sodium Hyaluronate/Trehalose/Carbomer Gel Following Strabismus SurgeryAldo Vagge, Giuseppe Giannaccare, Carlo Enrico Traverso
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|March 6, 2018
Kearns-Sayre syndrome with facial and white matter extensive involvement: a (mitochondrial and nuclear gene related?) neurocristopathy?Agostino Berio, Attilia Piazzi, Carlo Enrico Traverso
Investigative Ophthalmology & Visual Science|March 3, 2016
Choroidal Abnormalities Detected by Near-Infrared Imaging (NIR) in Pediatric Patients With Neurofibromatosis Type 1 (NF1)Aldo Vagge, Paolo Capris, Carlo Enrico Traverso
Expert Opinion on Therapeutic Targets|January 31, 2022
The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseasesLorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò
Drugs of Today (Barcelona, Spain : 1998)|November 24, 2022
Current treatment options for treating <i>OPA1</i>-mutant dominant optic atrophyLorenzo Ferro Desideri, Carlo Enrico Traverso, Michele Iester
Expert Opinion on Investigational Drugs|June 2, 2020
Abicipar pegol: an investigational anti-VEGF agent for the treatment of wet age-related macular degenerationLorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò
International Ophthalmology|August 10, 2020
An update on pharmacological treatment options for amblyopiaAldo Vagge, Lorenzo Ferro Desideri, Carlo Enrico Traverso
Ophthalmic Research|May 10, 2019
Bleb Needling with Mitomycin C as Adjunctive Therapy in Failing Blebs: A Retrospective StudyChiara Del Noce, Aldo Vagge, Carlo Enrico Traverso
Expert Opinion on Biological Therapy|April 26, 2021
Brolucizumab: a novel anti-VEGF humanized single-chain antibody fragment for treating w-AMDLorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Transactions of the American Ophthalmological Society|November 24, 2017
The Effects of Phacoemulsification and Intraocular Lens Implantation on Anatomical and Functional Parameters in Patients with Primary Angle Closure: A Prospective Study. (An American Ophthalmological Society Thesis)Carlo Enrico Traverso, Carlo Alberto Cutolo
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 13, 2019
Comparison of the Efficacy of Topical Chloramphenicol 0.5%-Betamethasone 0.2% (CB) and CB Associated with Sodium Hyaluronate/Trehalose/Carbomer Gel Following Strabismus SurgeryAldo Vagge, Giuseppe Giannaccare, Carlo Enrico Traverso
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|March 6, 2018
Kearns-Sayre syndrome with facial and white matter extensive involvement: a (mitochondrial and nuclear gene related?) neurocristopathy?Agostino Berio, Attilia Piazzi, Carlo Enrico Traverso
Investigative Ophthalmology & Visual Science|March 3, 2016
Choroidal Abnormalities Detected by Near-Infrared Imaging (NIR) in Pediatric Patients With Neurofibromatosis Type 1 (NF1)Aldo Vagge, Paolo Capris, Carlo Enrico Traverso
Expert Opinion on Therapeutic Targets|January 31, 2022
The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseasesLorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò
Drugs of Today (Barcelona, Spain : 1998)|November 24, 2022
Current treatment options for treating <i>OPA1</i>-mutant dominant optic atrophyLorenzo Ferro Desideri, Carlo Enrico Traverso, Michele Iester
Expert Opinion on Investigational Drugs|June 2, 2020
Abicipar pegol: an investigational anti-VEGF agent for the treatment of wet age-related macular degenerationLorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò
International Ophthalmology|August 10, 2020
An update on pharmacological treatment options for amblyopiaAldo Vagge, Lorenzo Ferro Desideri, Carlo Enrico Traverso
Ophthalmic Research|May 10, 2019
Bleb Needling with Mitomycin C as Adjunctive Therapy in Failing Blebs: A Retrospective StudyChiara Del Noce, Aldo Vagge, Carlo Enrico Traverso
Expert Opinion on Biological Therapy|April 26, 2021
Brolucizumab: a novel anti-VEGF humanized single-chain antibody fragment for treating w-AMDLorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò
Pageof 12